MAIA Biotechnology Inc
MAIA
Get informed when a big investor buys or sells
+ FollowMarket Cap$84.51M
Close$
$0.43
69.8% downside
Current Fair Value
69.8% downsideOvervalued by 69.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $84.51 Million |
|---|---|
| Enterprise Value | $50.10 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.7 |
| Beta | 0.23 |
| Outstanding Shares | 32,115,000 |
Return
| Return on Equity | -87.34% |
|---|---|
| Return on Assets | -68.65% |
| Return on Invested Capital | -87.37% |
Valuation & Multiples
| P/E Ratio | -1.84 |
|---|---|
| PEG | -4.49 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.98 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 11, 2026
EPS Estimate
$-0.18
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 10, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 40.85%▲ 33.27% |
|---|---|
| Total Invested | $18.36M▲ 348.71% |
| Investors Holding | 31▲ 5.00% |
ESG Score
No data